Global Therapeutic Nuclear Medicines Market Growth 2025-2031

Global Therapeutic Nuclear Medicines Market Growth 2025-2031

The global Therapeutic Nuclear Medicines market size is predicted to grow from US$ 2270 million in 2025 to US$ 6342 million in 2031; it is expected to grow at a CAGR of 18.7% from 2025 to 2031.

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.



Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 50 percent.

In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.

LP Information, Inc. (LPI) ' newest research report, the “Therapeutic Nuclear Medicines Industry Forecast” looks at past sales and reviews total world Therapeutic Nuclear Medicines sales in 2024, providing a comprehensive analysis by region and market sector of projected Therapeutic Nuclear Medicines sales for 2025 through 2031. With Therapeutic Nuclear Medicines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Nuclear Medicines industry.

This Insight Report provides a comprehensive analysis of the global Therapeutic Nuclear Medicines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Nuclear Medicines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Nuclear Medicines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Nuclear Medicines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Nuclear Medicines.

This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Nuclear Medicines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Radium-223
Lutetium-177
Iodine-131
Other

Segmentation by Application:
Thyroid
Bone Metastasis
Lymphoma
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes

Key Questions Addressed in this Report

What is the 10-year outlook for the global Therapeutic Nuclear Medicines market?

What factors are driving Therapeutic Nuclear Medicines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Therapeutic Nuclear Medicines market opportunities vary by end market size?

How does Therapeutic Nuclear Medicines break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.